Patients with chronic respiratory failure who meet usage criteria will have more access to respiratory assist devices.

Storied Japanese pharma Shionogi is upping its arsenal in the fight against antibiotic resistance. | Storied Japanese pharma ...

Bronchiectasis causes your airways, called bronchi, to become damaged and widened over time. When you have bronchiectasis, ...

Chronic obstructive pulmonary disease (COPD) affects 25 million people in the U.S. and is the fifth leading cause of death ...

Researchers looked at lung tissue from 28 COPD patients and 15 smokers who underwent surgery for suspected or confirmed lung ...

Women aged 40 years and older have a 50% greater risk for chronic obstructive pulmonary disease (COPD) vs men in the same age group, according to study findings published in BMJ Open Respiratory ...

COPD has a large economic impact on the healthcare system and a destructive impact on the lives of patients and their ...

According to a new comprehensive report from The Insight Partners, the global pulmonary drug delivery system market is ...

Regardless of chronic obstructive pulmonary disease status, finerenone mitigates clinical events and symptoms in patients with HFmrEF or HFpEF.

Investigators concluded that individuals with comorbidities experienced higher risks of severe COVID-19 outcomes during the ...